> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Hybrid Pharma Cited in 8-page Form 483 After Inspection
- URL: https://www.fdaweb.com/hybrid-pharma-cited-in-8-page-form-483-after-inspection/
- Published: 2016-08-29T12:00:00.000Z
- Updated: 2026-09-14T21:27:25.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5136636

Hybrid Pharma (Deerfield Beach, FL) has been cited in an eight-page [Form-483](http://www.fda.gov/ucm/groups/fdagov-public/@fdagov-afda-orgs/documents/document/ucm518163.pdf?ref=fdaweb.com) after a July inspection found that the firm had inadequate procedures designed to prevent microbiological contamination of drug products purporting to be sterile. The inspection also found the firm’s aseptic processing deficient regarding the system for cleaning and disinfecting the room and equipment to produce aseptic conditions. Additionally, the 483 said aseptic processing areas are deficient in their system for monitoring environmental conditions.